Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD
NCT04450875 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121
Last updated 2020-06-30
Summary
To assess the effect of a methionine metabolism-based dietary strategy in patients with non-alcoholic fatty liver disease in order to reduce complications while improving the quality of life for patients.
Conditions
- Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions
- DIETARY_SUPPLEMENT
-
Experimental group (with diet)
Two nutritionists performed both diet instruction and 24-hour reminder monitoring monthly. At the end of the three-month follow-up, the 24-hour reminder data such as food consumed, daily rations, and the monthly average of milligrams of consumed methionine contained in the food, were recorded in a database for subsequent analysis.
Sponsors & Collaborators
-
National Council of Science and Technology, Mexico
collaborator OTHER -
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
collaborator OTHER_GOV -
Universidad Veracruzana
lead OTHER
Principal Investigators
-
Rebeca García Román, PHD · UV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-24
- Primary Completion
- 2016-02-01
- Completion
- 2017-11-01
Countries
- Mexico
Study Locations
More Related Trials
-
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD
NCT05686174 ·Status: UNKNOWN ·Phase: PHASE1
-
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
NCT04330326 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
NCT02030977 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
NCT02194894 ·Status: WITHDRAWN ·Phase: NA
-
The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules
NCT05042245 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Healthy Adults Evaluating PF-07202954
NCT04857437 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
NCT05327127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group
NCT01754714 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).
NCT05946330 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
NCT02019056 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
NCT06873165 ·Status: RECRUITING ·Phase: NA
-
Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment
NCT04308980 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin
NCT01544751 ·Status: UNKNOWN ·Phase: NA
-
Effect of CoQ10 on the Outcome of MAFLD Patients
NCT05984745 ·Status: RECRUITING ·Phase: PHASE2
-
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
NCT02457286 ·Status: WITHDRAWN ·Phase: PHASE1
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT02927314 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease
NCT06739486 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease
NCT05084404 ·Status: UNKNOWN ·Phase: PHASE2
-
Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure
NCT03668171 ·Status: UNKNOWN ·Phase: NA
-
Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism
NCT04395950 ·Status: WITHDRAWN ·Phase: PHASE1
-
Acamprosate Safe to Use in Individuals With Liver Disease.
NCT04287920 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat
NCT07214870 ·Status: RECRUITING ·Phase: PHASE1
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Probiotics in the Treatment of NAFLD
NCT02764047 ·Status: UNKNOWN ·Phase: NA